Cargando…
Targeted AAV5-Smad7 gene therapy inhibits corneal scarring in vivo
Corneal scarring is due to aberrant activity of the transforming growth factor β (TGFβ) signaling pathway following traumatic, mechanical, infectious, or surgical injury. Altered TGFβ signaling cascade leads to downstream Smad (Suppressor of mothers against decapentaplegic) protein-mediated signalin...
Autores principales: | Gupta, Suneel, Rodier, Jason T., Sharma, Ajay, Giuliano, Elizabeth A., Sinha, Prashant R., Hesemann, Nathan P., Ghosh, Arkasubhra, Mohan, Rajiv R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365107/ https://www.ncbi.nlm.nih.gov/pubmed/28339457 http://dx.doi.org/10.1371/journal.pone.0172928 |
Ejemplares similares
-
Novel Combination BMP7 and HGF Gene Therapy Instigates Selective Myofibroblast Apoptosis and Reduces Corneal Haze In Vivo
por: Gupta, Suneel, et al.
Publicado: (2018) -
Role of inhibitor of differentiation 3 gene in cellular differentiation of human corneal stromal fibroblasts
por: Gupta, Suneel, et al.
Publicado: (2020) -
Long-Term Safety and Tolerability of BMP7 and HGF Gene Overexpression in Rabbit Cornea
por: Gupta, Suneel, et al.
Publicado: (2021) -
Six-Month In Vivo Safety Profiling of Topical Ocular AVV5–Decorin Gene Transfer
por: Mohan, Rajiv R., et al.
Publicado: (2021) -
A Novel Topical Ophthalmic Formulation to Mitigate Acute Mustard Gas Keratopathy In Vivo: A Pilot Study
por: Tripathi, Ratnakar, et al.
Publicado: (2020)